GenoSpace Completes Financing with Thomson Reuters

Funding Rounds

▤ Summary

GenoSpace, a Cambridge, MA-based precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, completed a financing deal with Thomson Reuters.The amount of the transaction, which marks the first investment in the precision medicine informatics market by Thomson Reuters, was not disclosed.The company intends to use the funds to accelerate expansion of its customer base in research, clinical development, laboratory medicine and clinical care.Led by John Quackenbush, CEO, GenoSpace provides a unified software platform that addresses the data access, analysis, interpretation and reporting needs of a diverse group of users including research scientists, pathologists, oncologists, clinical trial specialists, medical directors and patients.FinSMEs 12/08/2014

$ Funding

$
Amount $5.0M Total raised
□
Date August 12, 2014 Announcement date
◎
Investors Reuters Venture Capital Lead investors
▥
Company http://genospace.com Funded company

▥ Classifications

industries
Fintech & Banking
applications
Accounting and Taxes

◇ AskAI Classifications

Labels
Legal Tech Tax Software Compliance Software

▦ Linked Companies